Sign in

CIK 0001812364 · Large accelerated filer

Relay Therapeutics, Inc.

Sign in to watch
Ticker
RLAY
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
617-370-8837
Business address
60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$120,165,474
in 11 filings, $3.7M under 10b5-1 plans

Net −$120,165,474. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-05-19 Rubin Jami Director Grant or award · Stock Option (Right to Buy) +16,000 16,000
2021-05-19 Murcko Mark Director Grant or award · Stock Option (Right to Buy) +16,000 16,000
2021-05-19 Borisy Alexis Director Grant or award · Stock Option (Right to Buy) +16,000 16,000
2021-05-19 INGRAM DOUGLAS S Director Grant or award · Stock Option (Right to Buy) +16,000 16,000
2021-05-19 HILL LINDA A Director Grant or award · Stock Option (Right to Buy) +16,000 16,000
2021-04-26 Adams Brian General Counsel Option exercise +6,500 $4.12 $27K 32,370
2021-04-26 Adams Brian General Counsel Sale −6,500 $35.00 $228K 25,870
2021-04-26 Adams Brian General Counsel Option exercise · Stock Option (Right to Buy) −6,500 160,286
2021-04-16 Bergstrom Donald A See Remarks Sale −56,324 $32.36 $1.8M 77,241
2021-03-30 Catinazzo Thomas Senior Vice President, Finance Option exercise +22,500 $4.12 $93K 38,370
2021-03-30 Catinazzo Thomas Senior Vice President, Finance Sale −22,500 $35.00 $788K 15,870
2021-03-30 Catinazzo Thomas Senior Vice President, Finance Option exercise · Stock Option (Right to Buy) −22,500 107,043
2021-03-30 Catinazzo Thomas Senior Vice President, Finance Option exercise +22,500 $4.12 $93K 22,500
2021-03-30 Catinazzo Thomas Senior Vice President, Finance Sale −22,500 $35.00 $788K 0
2021-03-30 Catinazzo Thomas Senior Vice President, Finance Option exercise · Stock Option (Right to Buy) −22,500 107,043
2021-03-26 Bergstrom Donald A See Remarks Grant or award +34,999 133,565
2021-03-26 Bergstrom Donald A See Remarks Grant or award · Stock Option (Right to Buy) +69,998 69,998
2021-03-26 Patel Sanjiv President and CEO Grant or award · Stock Option (Right to Buy) +325,000 325,000
2021-03-26 Catinazzo Thomas Senior Vice President, Finance Grant or award +15,870 15,870
2021-03-26 Catinazzo Thomas Senior Vice President, Finance Grant or award · Stock Option (Right to Buy) +31,740 31,740

Page 24 of 27 · 534 trades